Literature DB >> 15924076

[Pain in Parkinson's disease].

R Giuffrida1, F J G Vingerhoets, J Bogousslavsky, J Ghika.   

Abstract

INTRODUCTION: Pain may be a presenting symptom of Parkinson's disease or may occur during the motor fluctuation stages of the disease. The complexity and pathophysiology of pain in Parkinson's disease still remains poorly understood.
OBJECTIVE: To characterize clinically the different painful presentations of Parkinson's disease, their relationship to the stage of the disease and their connections with motor fluctuations and treatment.
METHODS: We reviewed painful syndromes in 388 consecutive parkinsonian patients of the Lausanne Movement Disorders Registry, based on an itemized questionnaire used prospectively to characterize the pain by its description, topography, date of appearance and possible relationship with motor fluctuations. Among these patients with clinically-diagnosed dopa-responsive Parkinson's disease, 269, i.e. 67 percent presented sensory or painful syndromes. Among them, 94 percent had muscular pain: stiffness (85 percent), cramps, pseudo-cramps, spasms (3 percent) or various myalgias (7 percent); 51 percent presented osteo-ligamentar "rheumatologic" pain, articular (23 percent), periarticular (3 percent) or spinal (31 percent), but less defined and localized neurogenic painful syndromes were less frequent (8 percent), such as paresthesia (6 percent), dysesthesia (<1 percent), burning sensation (2 percent), itching (<1 percent), ill defined discomfort (6 percent) or a feeling of heaviness (1 percent), with segmental (86 percent), axial (54 percent), radicular or pseudo-radicular (14 percent), acral distal (4 percent) or less frequently anorectal or visceral distribution. Restless legs or akathisia were occasional (10 percent). Headaches and facial pain were less frequent (1 percent), we did not encounter phantom pain. More than one quarter were present at the beginning of the disease, only (3 percent) of them resolved during the development of the disease. About one-third were clearly linked with motor fluctuations, the majority occurring in off phase (34 percent). We did not find any correlation with age, gender, duration or stage of disease, L dopa equivalent dose, depression, insomnia or autonomic dysfunction.
CONCLUSION: Painful syndromes are found in two thirds of patients with Parkinson's disease, with mainly pain of muscular origin, followed by osteoarticular and neurogenic painful syndromes, a quarter of the patients experience pain in early phases of the disease and a third in relation with motor fluctuations.

Entities:  

Mesh:

Year:  2005        PMID: 15924076     DOI: 10.1016/s0035-3787(05)85070-2

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  13 in total

Review 1.  Evidence for the use of cannabinoids in Parkinson's disease.

Authors:  Carsten Buhmann; Tina Mainka; Georg Ebersbach; Florin Gandor
Journal:  J Neural Transm (Vienna)       Date:  2019-05-27       Impact factor: 3.575

Review 2.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

3.  Pain and motor complications in Parkinson's disease.

Authors:  M Tinazzi; C Del Vesco; E Fincati; S Ottaviani; N Smania; G Moretto; A Fiaschi; D Martino; G Defazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-20       Impact factor: 10.154

Review 4.  Pains in Parkinson disease--many syndromes under one umbrella.

Authors:  Gunnar Wasner; Günther Deuschl
Journal:  Nat Rev Neurol       Date:  2012-04-17       Impact factor: 42.937

5.  Changes to Ventilation, Vocalization, and Thermal Nociception in the Pink1-/- Rat Model of Parkinson's Disease.

Authors:  Rebecca A Johnson; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 6.  Preclinical and early clinical investigations related to monoaminergic pain modulation.

Authors:  Kirsty Bannister; Lucy A Bee; Anthony H Dickenson
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

7.  Chronic subthalamic deep brain stimulation improves pain in Parkinson disease.

Authors:  Han-Joon Kim; Sun Ha Paek; Ji-Young Kim; Jee-Young Lee; Yong Hoon Lim; Mi-Ryoung Kim; Dong Gyu Kim; Beom S Jeon
Journal:  J Neurol       Date:  2009-01-22       Impact factor: 4.849

8.  [Lumbar back pain in patients with Parkinson's disease].

Authors:  O Rommel; D Wejwer; K Schybek; T Przybilski; G Jäger; S Gräber; D Berg
Journal:  Nervenarzt       Date:  2016-04       Impact factor: 1.214

9.  Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study.

Authors:  A Gerdelat-Mas; M Simonetta-Moreau; C Thalamas; F Ory-Magne; T Slaoui; O Rascol; C Brefel-Courbon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05-15       Impact factor: 10.154

10.  Parkinson's disease patients' subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life.

Authors:  Orjan Skogar; Per-Arne Fall; Gunnar Hallgren; Birgitta Bringer; Miriam Carlsson; Ulla Lennartsson; Håkan Sandbjörk; Carl-Johan Törnhage; Johan Lökk
Journal:  Neuropsychiatr Dis Treat       Date:  2012-10-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.